Clinical study on prevention of propofol injection pain by TAES combined with lidocaine

Phase 1

Completed

• Conditions: Propofol injection pain

• Registration Number: ITMCTR2000003873
• Lead Sponsor: Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

1. Women aged 18 to 65 years who were selected for painless hysteroscopy;
2. ASA grade I-II;
3. BMI kg/m2 18-31;
4. No contraindication of propofol and lidocaine;
5. informed consent to this pre-treatment programme.

Exclusion Criteria

1. meridian points have surgical incision or scar;
2. patients with local skin infection at acupoints;
3. patients with upper or lower limb nerve damage;
4. have a history of spinal surgery;
5. other clinical trials in the last four weeks;
6. can't understand NRS score;
7. patients with history of allergy to lipids, propofol, local anesthetics (lidocaine) and general anesthesia;
8. patients with forearm thrombophlebitis or acute and chronic pain syndrome;
9. has a history of gastrointestinal ulcers and analgesic and sedative drug abuse;
10. Severe mental illness or Patients with dyslexia;
11. Patients with chronic pain syndrome, thrombophlebitis, neurological disorders;
12. The researchers found it inappropriate to participate in the trial.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS;